Recombinant Vector Vaccines Market, Global Outlook and Forecast 2022-2028
Recombinant vector vaccines are experimental vaccines similar to DNA vaccines, but they use an attenuated virus or bacterium to introduce microbial DNA to cells of the body. “Vector” refers to the virus or bacterium used as the carrier.
In nature, viruses latch on to cells and inject their genetic material into them. In the lab, scientists have taken advantage of this process. They have figured out how to take the roomy genomes of certain harmless or attenuated viruses and insert portions of the genetic material from other microbes into them. The carrier viruses then ferry that microbial DNA to cells. Recombinant vector vaccines closely mimic a natural infection and therefore do a good job of stimulating the immune system.
Attenuated bacteria also can be used as vectors. In this case, the inserted genetic material causes the bacteria to display the antigens of other microbes on its surface. In effect, the harmless bacterium mimics a harmful microbe, provoking an immune response.
Researchers are working on both bacteria-l and viral-based recombinant vector vaccines for HIV, rabies, and measles.
This report contains market size and forecasts of Recombinant Vector Vaccines in global, including the following market information:
Global Recombinant Vector Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Recombinant Vector Vaccines Market Sales, 2017-2022, 2023-2028, (K Doses)
Global top five Recombinant Vector Vaccines companies in 2021 (%)
The global Recombinant Vector Vaccines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Varicella Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Recombinant Vector Vaccines include SANOFI PASTEUR S.A., Novartis, GSK, CNBG, ChengDa Bio, Changsheng Life, Zhifei, SINOVAC BIOTECH and NuoCheng Bio, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Recombinant Vector Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Recombinant Vector Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Recombinant Vector Vaccines Market Segment Percentages, by Type, 2021 (%)
Global Recombinant Vector Vaccines Market Segment Percentages, by Application, 2021 (%)
Global Recombinant Vector Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Recombinant Vector Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Recombinant Vector Vaccines revenues share in global market, 2021 (%)
Key companies Recombinant Vector Vaccines sales in global market, 2017-2022 (Estimated), (K Doses)
Key companies Recombinant Vector Vaccines sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
In nature, viruses latch on to cells and inject their genetic material into them. In the lab, scientists have taken advantage of this process. They have figured out how to take the roomy genomes of certain harmless or attenuated viruses and insert portions of the genetic material from other microbes into them. The carrier viruses then ferry that microbial DNA to cells. Recombinant vector vaccines closely mimic a natural infection and therefore do a good job of stimulating the immune system.
Attenuated bacteria also can be used as vectors. In this case, the inserted genetic material causes the bacteria to display the antigens of other microbes on its surface. In effect, the harmless bacterium mimics a harmful microbe, provoking an immune response.
Researchers are working on both bacteria-l and viral-based recombinant vector vaccines for HIV, rabies, and measles.
This report contains market size and forecasts of Recombinant Vector Vaccines in global, including the following market information:
Global Recombinant Vector Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Recombinant Vector Vaccines Market Sales, 2017-2022, 2023-2028, (K Doses)
Global top five Recombinant Vector Vaccines companies in 2021 (%)
The global Recombinant Vector Vaccines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Varicella Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Recombinant Vector Vaccines include SANOFI PASTEUR S.A., Novartis, GSK, CNBG, ChengDa Bio, Changsheng Life, Zhifei, SINOVAC BIOTECH and NuoCheng Bio, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Recombinant Vector Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Recombinant Vector Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Recombinant Vector Vaccines Market Segment Percentages, by Type, 2021 (%)
- Varicella
- Influenza
- Polio
- Hepatitis A
- Rabies
- BCG
- Hepatitis B
- Pertussis, Diphtheria, tetanus
- Pneumococcal
- Others
Global Recombinant Vector Vaccines Market Segment Percentages, by Application, 2021 (%)
- For Adult
- For Child
Global Recombinant Vector Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Recombinant Vector Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Recombinant Vector Vaccines revenues share in global market, 2021 (%)
Key companies Recombinant Vector Vaccines sales in global market, 2017-2022 (Estimated), (K Doses)
Key companies Recombinant Vector Vaccines sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- SANOFI PASTEUR S.A.
- Novartis
- GSK
- CNBG
- ChengDa Bio
- Changsheng Life
- Zhifei
- SINOVAC BIOTECH
- NuoCheng Bio
- Hualan Bio
- Kangtai
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Recombinant Vector Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Recombinant Vector Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL RECOMBINANT VECTOR VACCINES OVERALL MARKET SIZE
2.1 Global Recombinant Vector Vaccines Market Size: 2021 VS 2028
2.2 Global Recombinant Vector Vaccines Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Recombinant Vector Vaccines Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Recombinant Vector Vaccines Players in Global Market
3.2 Top Global Recombinant Vector Vaccines Companies Ranked by Revenue
3.3 Global Recombinant Vector Vaccines Revenue by Companies
3.4 Global Recombinant Vector Vaccines Sales by Companies
3.5 Global Recombinant Vector Vaccines Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Recombinant Vector Vaccines Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Recombinant Vector Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Recombinant Vector Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Recombinant Vector Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Recombinant Vector Vaccines Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Recombinant Vector Vaccines Market Size Markets, 2021 & 2028
4.1.2 Varicella
4.1.3 Influenza
4.1.4 Polio
4.1.5 Hepatitis A
4.1.6 Rabies
4.1.7 BCG
4.1.8 Hepatitis B
4.1.9 Pertussis, Diphtheria, tetanus
4.1.10 Pneumococcal
4.1.11 Others
4.2 By Type - Global Recombinant Vector Vaccines Revenue & Forecasts
4.2.1 By Type - Global Recombinant Vector Vaccines Revenue, 2017-2022
4.2.2 By Type - Global Recombinant Vector Vaccines Revenue, 2023-2028
4.2.3 By Type - Global Recombinant Vector Vaccines Revenue Market Share, 2017-2028
4.3 By Type - Global Recombinant Vector Vaccines Sales & Forecasts
4.3.1 By Type - Global Recombinant Vector Vaccines Sales, 2017-2022
4.3.2 By Type - Global Recombinant Vector Vaccines Sales, 2023-2028
4.3.3 By Type - Global Recombinant Vector Vaccines Sales Market Share, 2017-2028
4.4 By Type - Global Recombinant Vector Vaccines Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Recombinant Vector Vaccines Market Size, 2021 & 2028
5.1.2 For Adult
5.1.3 For Child
5.2 By Application - Global Recombinant Vector Vaccines Revenue & Forecasts
5.2.1 By Application - Global Recombinant Vector Vaccines Revenue, 2017-2022
5.2.2 By Application - Global Recombinant Vector Vaccines Revenue, 2023-2028
5.2.3 By Application - Global Recombinant Vector Vaccines Revenue Market Share, 2017-2028
5.3 By Application - Global Recombinant Vector Vaccines Sales & Forecasts
5.3.1 By Application - Global Recombinant Vector Vaccines Sales, 2017-2022
5.3.2 By Application - Global Recombinant Vector Vaccines Sales, 2023-2028
5.3.3 By Application - Global Recombinant Vector Vaccines Sales Market Share, 2017-2028
5.4 By Application - Global Recombinant Vector Vaccines Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Recombinant Vector Vaccines Market Size, 2021 & 2028
6.2 By Region - Global Recombinant Vector Vaccines Revenue & Forecasts
6.2.1 By Region - Global Recombinant Vector Vaccines Revenue, 2017-2022
6.2.2 By Region - Global Recombinant Vector Vaccines Revenue, 2023-2028
6.2.3 By Region - Global Recombinant Vector Vaccines Revenue Market Share, 2017-2028
6.3 By Region - Global Recombinant Vector Vaccines Sales & Forecasts
6.3.1 By Region - Global Recombinant Vector Vaccines Sales, 2017-2022
6.3.2 By Region - Global Recombinant Vector Vaccines Sales, 2023-2028
6.3.3 By Region - Global Recombinant Vector Vaccines Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Recombinant Vector Vaccines Revenue, 2017-2028
6.4.2 By Country - North America Recombinant Vector Vaccines Sales, 2017-2028
6.4.3 US Recombinant Vector Vaccines Market Size, 2017-2028
6.4.4 Canada Recombinant Vector Vaccines Market Size, 2017-2028
6.4.5 Mexico Recombinant Vector Vaccines Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Recombinant Vector Vaccines Revenue, 2017-2028
6.5.2 By Country - Europe Recombinant Vector Vaccines Sales, 2017-2028
6.5.3 Germany Recombinant Vector Vaccines Market Size, 2017-2028
6.5.4 France Recombinant Vector Vaccines Market Size, 2017-2028
6.5.5 U.K. Recombinant Vector Vaccines Market Size, 2017-2028
6.5.6 Italy Recombinant Vector Vaccines Market Size, 2017-2028
6.5.7 Russia Recombinant Vector Vaccines Market Size, 2017-2028
6.5.8 Nordic Countries Recombinant Vector Vaccines Market Size, 2017-2028
6.5.9 Benelux Recombinant Vector Vaccines Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Recombinant Vector Vaccines Revenue, 2017-2028
6.6.2 By Region - Asia Recombinant Vector Vaccines Sales, 2017-2028
6.6.3 China Recombinant Vector Vaccines Market Size, 2017-2028
6.6.4 Japan Recombinant Vector Vaccines Market Size, 2017-2028
6.6.5 South Korea Recombinant Vector Vaccines Market Size, 2017-2028
6.6.6 Southeast Asia Recombinant Vector Vaccines Market Size, 2017-2028
6.6.7 India Recombinant Vector Vaccines Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Recombinant Vector Vaccines Revenue, 2017-2028
6.7.2 By Country - South America Recombinant Vector Vaccines Sales, 2017-2028
6.7.3 Brazil Recombinant Vector Vaccines Market Size, 2017-2028
6.7.4 Argentina Recombinant Vector Vaccines Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Recombinant Vector Vaccines Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Recombinant Vector Vaccines Sales, 2017-2028
6.8.3 Turkey Recombinant Vector Vaccines Market Size, 2017-2028
6.8.4 Israel Recombinant Vector Vaccines Market Size, 2017-2028
6.8.5 Saudi Arabia Recombinant Vector Vaccines Market Size, 2017-2028
6.8.6 UAE Recombinant Vector Vaccines Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 SANOFI PASTEUR S.A.
7.1.1 SANOFI PASTEUR S.A. Corporate Summary
7.1.2 SANOFI PASTEUR S.A. Business Overview
7.1.3 SANOFI PASTEUR S.A. Recombinant Vector Vaccines Major Product Offerings
7.1.4 SANOFI PASTEUR S.A. Recombinant Vector Vaccines Sales and Revenue in Global (2017-2022)
7.1.5 SANOFI PASTEUR S.A. Key News
7.2 Novartis
7.2.1 Novartis Corporate Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Recombinant Vector Vaccines Major Product Offerings
7.2.4 Novartis Recombinant Vector Vaccines Sales and Revenue in Global (2017-2022)
7.2.5 Novartis Key News
7.3 GSK
7.3.1 GSK Corporate Summary
7.3.2 GSK Business Overview
7.3.3 GSK Recombinant Vector Vaccines Major Product Offerings
7.3.4 GSK Recombinant Vector Vaccines Sales and Revenue in Global (2017-2022)
7.3.5 GSK Key News
7.4 CNBG
7.4.1 CNBG Corporate Summary
7.4.2 CNBG Business Overview
7.4.3 CNBG Recombinant Vector Vaccines Major Product Offerings
7.4.4 CNBG Recombinant Vector Vaccines Sales and Revenue in Global (2017-2022)
7.4.5 CNBG Key News
7.5 ChengDa Bio
7.5.1 ChengDa Bio Corporate Summary
7.5.2 ChengDa Bio Business Overview
7.5.3 ChengDa Bio Recombinant Vector Vaccines Major Product Offerings
7.5.4 ChengDa Bio Recombinant Vector Vaccines Sales and Revenue in Global (2017-2022)
7.5.5 ChengDa Bio Key News
7.6 Changsheng Life
7.6.1 Changsheng Life Corporate Summary
7.6.2 Changsheng Life Business Overview
7.6.3 Changsheng Life Recombinant Vector Vaccines Major Product Offerings
7.6.4 Changsheng Life Recombinant Vector Vaccines Sales and Revenue in Global (2017-2022)
7.6.5 Changsheng Life Key News
7.7 Zhifei
7.7.1 Zhifei Corporate Summary
7.7.2 Zhifei Business Overview
7.7.3 Zhifei Recombinant Vector Vaccines Major Product Offerings
7.7.4 Zhifei Recombinant Vector Vaccines Sales and Revenue in Global (2017-2022)
7.7.5 Zhifei Key News
7.8 SINOVAC BIOTECH
7.8.1 SINOVAC BIOTECH Corporate Summary
7.8.2 SINOVAC BIOTECH Business Overview
7.8.3 SINOVAC BIOTECH Recombinant Vector Vaccines Major Product Offerings
7.8.4 SINOVAC BIOTECH Recombinant Vector Vaccines Sales and Revenue in Global (2017-2022)
7.8.5 SINOVAC BIOTECH Key News
7.9 NuoCheng Bio
7.9.1 NuoCheng Bio Corporate Summary
7.9.2 NuoCheng Bio Business Overview
7.9.3 NuoCheng Bio Recombinant Vector Vaccines Major Product Offerings
7.9.4 NuoCheng Bio Recombinant Vector Vaccines Sales and Revenue in Global (2017-2022)
7.9.5 NuoCheng Bio Key News
7.10 Hualan Bio
7.10.1 Hualan Bio Corporate Summary
7.10.2 Hualan Bio Business Overview
7.10.3 Hualan Bio Recombinant Vector Vaccines Major Product Offerings
7.10.4 Hualan Bio Recombinant Vector Vaccines Sales and Revenue in Global (2017-2022)
7.10.5 Hualan Bio Key News
7.11 Kangtai
7.11.1 Kangtai Corporate Summary
7.11.2 Kangtai Recombinant Vector Vaccines Business Overview
7.11.3 Kangtai Recombinant Vector Vaccines Major Product Offerings
7.11.4 Kangtai Recombinant Vector Vaccines Sales and Revenue in Global (2017-2022)
7.11.5 Kangtai Key News
8 GLOBAL RECOMBINANT VECTOR VACCINES PRODUCTION CAPACITY, ANALYSIS
8.1 Global Recombinant Vector Vaccines Production Capacity, 2017-2028
8.2 Recombinant Vector Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Recombinant Vector Vaccines Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 RECOMBINANT VECTOR VACCINES SUPPLY CHAIN ANALYSIS
10.1 Recombinant Vector Vaccines Industry Value Chain
10.2 Recombinant Vector Vaccines Upstream Market
10.3 Recombinant Vector Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Recombinant Vector Vaccines Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Recombinant Vector Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Recombinant Vector Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL RECOMBINANT VECTOR VACCINES OVERALL MARKET SIZE
2.1 Global Recombinant Vector Vaccines Market Size: 2021 VS 2028
2.2 Global Recombinant Vector Vaccines Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Recombinant Vector Vaccines Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Recombinant Vector Vaccines Players in Global Market
3.2 Top Global Recombinant Vector Vaccines Companies Ranked by Revenue
3.3 Global Recombinant Vector Vaccines Revenue by Companies
3.4 Global Recombinant Vector Vaccines Sales by Companies
3.5 Global Recombinant Vector Vaccines Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Recombinant Vector Vaccines Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Recombinant Vector Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Recombinant Vector Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Recombinant Vector Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Recombinant Vector Vaccines Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Recombinant Vector Vaccines Market Size Markets, 2021 & 2028
4.1.2 Varicella
4.1.3 Influenza
4.1.4 Polio
4.1.5 Hepatitis A
4.1.6 Rabies
4.1.7 BCG
4.1.8 Hepatitis B
4.1.9 Pertussis, Diphtheria, tetanus
4.1.10 Pneumococcal
4.1.11 Others
4.2 By Type - Global Recombinant Vector Vaccines Revenue & Forecasts
4.2.1 By Type - Global Recombinant Vector Vaccines Revenue, 2017-2022
4.2.2 By Type - Global Recombinant Vector Vaccines Revenue, 2023-2028
4.2.3 By Type - Global Recombinant Vector Vaccines Revenue Market Share, 2017-2028
4.3 By Type - Global Recombinant Vector Vaccines Sales & Forecasts
4.3.1 By Type - Global Recombinant Vector Vaccines Sales, 2017-2022
4.3.2 By Type - Global Recombinant Vector Vaccines Sales, 2023-2028
4.3.3 By Type - Global Recombinant Vector Vaccines Sales Market Share, 2017-2028
4.4 By Type - Global Recombinant Vector Vaccines Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Recombinant Vector Vaccines Market Size, 2021 & 2028
5.1.2 For Adult
5.1.3 For Child
5.2 By Application - Global Recombinant Vector Vaccines Revenue & Forecasts
5.2.1 By Application - Global Recombinant Vector Vaccines Revenue, 2017-2022
5.2.2 By Application - Global Recombinant Vector Vaccines Revenue, 2023-2028
5.2.3 By Application - Global Recombinant Vector Vaccines Revenue Market Share, 2017-2028
5.3 By Application - Global Recombinant Vector Vaccines Sales & Forecasts
5.3.1 By Application - Global Recombinant Vector Vaccines Sales, 2017-2022
5.3.2 By Application - Global Recombinant Vector Vaccines Sales, 2023-2028
5.3.3 By Application - Global Recombinant Vector Vaccines Sales Market Share, 2017-2028
5.4 By Application - Global Recombinant Vector Vaccines Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Recombinant Vector Vaccines Market Size, 2021 & 2028
6.2 By Region - Global Recombinant Vector Vaccines Revenue & Forecasts
6.2.1 By Region - Global Recombinant Vector Vaccines Revenue, 2017-2022
6.2.2 By Region - Global Recombinant Vector Vaccines Revenue, 2023-2028
6.2.3 By Region - Global Recombinant Vector Vaccines Revenue Market Share, 2017-2028
6.3 By Region - Global Recombinant Vector Vaccines Sales & Forecasts
6.3.1 By Region - Global Recombinant Vector Vaccines Sales, 2017-2022
6.3.2 By Region - Global Recombinant Vector Vaccines Sales, 2023-2028
6.3.3 By Region - Global Recombinant Vector Vaccines Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Recombinant Vector Vaccines Revenue, 2017-2028
6.4.2 By Country - North America Recombinant Vector Vaccines Sales, 2017-2028
6.4.3 US Recombinant Vector Vaccines Market Size, 2017-2028
6.4.4 Canada Recombinant Vector Vaccines Market Size, 2017-2028
6.4.5 Mexico Recombinant Vector Vaccines Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Recombinant Vector Vaccines Revenue, 2017-2028
6.5.2 By Country - Europe Recombinant Vector Vaccines Sales, 2017-2028
6.5.3 Germany Recombinant Vector Vaccines Market Size, 2017-2028
6.5.4 France Recombinant Vector Vaccines Market Size, 2017-2028
6.5.5 U.K. Recombinant Vector Vaccines Market Size, 2017-2028
6.5.6 Italy Recombinant Vector Vaccines Market Size, 2017-2028
6.5.7 Russia Recombinant Vector Vaccines Market Size, 2017-2028
6.5.8 Nordic Countries Recombinant Vector Vaccines Market Size, 2017-2028
6.5.9 Benelux Recombinant Vector Vaccines Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Recombinant Vector Vaccines Revenue, 2017-2028
6.6.2 By Region - Asia Recombinant Vector Vaccines Sales, 2017-2028
6.6.3 China Recombinant Vector Vaccines Market Size, 2017-2028
6.6.4 Japan Recombinant Vector Vaccines Market Size, 2017-2028
6.6.5 South Korea Recombinant Vector Vaccines Market Size, 2017-2028
6.6.6 Southeast Asia Recombinant Vector Vaccines Market Size, 2017-2028
6.6.7 India Recombinant Vector Vaccines Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Recombinant Vector Vaccines Revenue, 2017-2028
6.7.2 By Country - South America Recombinant Vector Vaccines Sales, 2017-2028
6.7.3 Brazil Recombinant Vector Vaccines Market Size, 2017-2028
6.7.4 Argentina Recombinant Vector Vaccines Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Recombinant Vector Vaccines Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Recombinant Vector Vaccines Sales, 2017-2028
6.8.3 Turkey Recombinant Vector Vaccines Market Size, 2017-2028
6.8.4 Israel Recombinant Vector Vaccines Market Size, 2017-2028
6.8.5 Saudi Arabia Recombinant Vector Vaccines Market Size, 2017-2028
6.8.6 UAE Recombinant Vector Vaccines Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 SANOFI PASTEUR S.A.
7.1.1 SANOFI PASTEUR S.A. Corporate Summary
7.1.2 SANOFI PASTEUR S.A. Business Overview
7.1.3 SANOFI PASTEUR S.A. Recombinant Vector Vaccines Major Product Offerings
7.1.4 SANOFI PASTEUR S.A. Recombinant Vector Vaccines Sales and Revenue in Global (2017-2022)
7.1.5 SANOFI PASTEUR S.A. Key News
7.2 Novartis
7.2.1 Novartis Corporate Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Recombinant Vector Vaccines Major Product Offerings
7.2.4 Novartis Recombinant Vector Vaccines Sales and Revenue in Global (2017-2022)
7.2.5 Novartis Key News
7.3 GSK
7.3.1 GSK Corporate Summary
7.3.2 GSK Business Overview
7.3.3 GSK Recombinant Vector Vaccines Major Product Offerings
7.3.4 GSK Recombinant Vector Vaccines Sales and Revenue in Global (2017-2022)
7.3.5 GSK Key News
7.4 CNBG
7.4.1 CNBG Corporate Summary
7.4.2 CNBG Business Overview
7.4.3 CNBG Recombinant Vector Vaccines Major Product Offerings
7.4.4 CNBG Recombinant Vector Vaccines Sales and Revenue in Global (2017-2022)
7.4.5 CNBG Key News
7.5 ChengDa Bio
7.5.1 ChengDa Bio Corporate Summary
7.5.2 ChengDa Bio Business Overview
7.5.3 ChengDa Bio Recombinant Vector Vaccines Major Product Offerings
7.5.4 ChengDa Bio Recombinant Vector Vaccines Sales and Revenue in Global (2017-2022)
7.5.5 ChengDa Bio Key News
7.6 Changsheng Life
7.6.1 Changsheng Life Corporate Summary
7.6.2 Changsheng Life Business Overview
7.6.3 Changsheng Life Recombinant Vector Vaccines Major Product Offerings
7.6.4 Changsheng Life Recombinant Vector Vaccines Sales and Revenue in Global (2017-2022)
7.6.5 Changsheng Life Key News
7.7 Zhifei
7.7.1 Zhifei Corporate Summary
7.7.2 Zhifei Business Overview
7.7.3 Zhifei Recombinant Vector Vaccines Major Product Offerings
7.7.4 Zhifei Recombinant Vector Vaccines Sales and Revenue in Global (2017-2022)
7.7.5 Zhifei Key News
7.8 SINOVAC BIOTECH
7.8.1 SINOVAC BIOTECH Corporate Summary
7.8.2 SINOVAC BIOTECH Business Overview
7.8.3 SINOVAC BIOTECH Recombinant Vector Vaccines Major Product Offerings
7.8.4 SINOVAC BIOTECH Recombinant Vector Vaccines Sales and Revenue in Global (2017-2022)
7.8.5 SINOVAC BIOTECH Key News
7.9 NuoCheng Bio
7.9.1 NuoCheng Bio Corporate Summary
7.9.2 NuoCheng Bio Business Overview
7.9.3 NuoCheng Bio Recombinant Vector Vaccines Major Product Offerings
7.9.4 NuoCheng Bio Recombinant Vector Vaccines Sales and Revenue in Global (2017-2022)
7.9.5 NuoCheng Bio Key News
7.10 Hualan Bio
7.10.1 Hualan Bio Corporate Summary
7.10.2 Hualan Bio Business Overview
7.10.3 Hualan Bio Recombinant Vector Vaccines Major Product Offerings
7.10.4 Hualan Bio Recombinant Vector Vaccines Sales and Revenue in Global (2017-2022)
7.10.5 Hualan Bio Key News
7.11 Kangtai
7.11.1 Kangtai Corporate Summary
7.11.2 Kangtai Recombinant Vector Vaccines Business Overview
7.11.3 Kangtai Recombinant Vector Vaccines Major Product Offerings
7.11.4 Kangtai Recombinant Vector Vaccines Sales and Revenue in Global (2017-2022)
7.11.5 Kangtai Key News
8 GLOBAL RECOMBINANT VECTOR VACCINES PRODUCTION CAPACITY, ANALYSIS
8.1 Global Recombinant Vector Vaccines Production Capacity, 2017-2028
8.2 Recombinant Vector Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Recombinant Vector Vaccines Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 RECOMBINANT VECTOR VACCINES SUPPLY CHAIN ANALYSIS
10.1 Recombinant Vector Vaccines Industry Value Chain
10.2 Recombinant Vector Vaccines Upstream Market
10.3 Recombinant Vector Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Recombinant Vector Vaccines Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Recombinant Vector Vaccines in Global Market
Table 2. Top Recombinant Vector Vaccines Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Recombinant Vector Vaccines Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Recombinant Vector Vaccines Revenue Share by Companies, 2017-2022
Table 5. Global Recombinant Vector Vaccines Sales by Companies, (K Doses), 2017-2022
Table 6. Global Recombinant Vector Vaccines Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Recombinant Vector Vaccines Price (2017-2022) & (USD/Dose)
Table 8. Global Manufacturers Recombinant Vector Vaccines Product Type
Table 9. List of Global Tier 1 Recombinant Vector Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Recombinant Vector Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Recombinant Vector Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Recombinant Vector Vaccines Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Recombinant Vector Vaccines Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Recombinant Vector Vaccines Sales (K Doses), 2017-2022
Table 15. By Type - Global Recombinant Vector Vaccines Sales (K Doses), 2023-2028
Table 16. By Application – Global Recombinant Vector Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Recombinant Vector Vaccines Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Recombinant Vector Vaccines Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Recombinant Vector Vaccines Sales (K Doses), 2017-2022
Table 20. By Application - Global Recombinant Vector Vaccines Sales (K Doses), 2023-2028
Table 21. By Region – Global Recombinant Vector Vaccines Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Recombinant Vector Vaccines Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Recombinant Vector Vaccines Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Recombinant Vector Vaccines Sales (K Doses), 2017-2022
Table 25. By Region - Global Recombinant Vector Vaccines Sales (K Doses), 2023-2028
Table 26. By Country - North America Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Recombinant Vector Vaccines Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Recombinant Vector Vaccines Sales, (K Doses), 2017-2022
Table 29. By Country - North America Recombinant Vector Vaccines Sales, (K Doses), 2023-2028
Table 30. By Country - Europe Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Recombinant Vector Vaccines Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Recombinant Vector Vaccines Sales, (K Doses), 2017-2022
Table 33. By Country - Europe Recombinant Vector Vaccines Sales, (K Doses), 2023-2028
Table 34. By Region - Asia Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Recombinant Vector Vaccines Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Recombinant Vector Vaccines Sales, (K Doses), 2017-2022
Table 37. By Region - Asia Recombinant Vector Vaccines Sales, (K Doses), 2023-2028
Table 38. By Country - South America Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Recombinant Vector Vaccines Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Recombinant Vector Vaccines Sales, (K Doses), 2017-2022
Table 41. By Country - South America Recombinant Vector Vaccines Sales, (K Doses), 2023-2028
Table 42. By Country - Middle East & Africa Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Recombinant Vector Vaccines Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Recombinant Vector Vaccines Sales, (K Doses), 2017-2022
Table 45. By Country - Middle East & Africa Recombinant Vector Vaccines Sales, (K Doses), 2023-2028
Table 46. SANOFI PASTEUR S.A. Corporate Summary
Table 47. SANOFI PASTEUR S.A. Recombinant Vector Vaccines Product Offerings
Table 48. SANOFI PASTEUR S.A. Recombinant Vector Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 49. Novartis Corporate Summary
Table 50. Novartis Recombinant Vector Vaccines Product Offerings
Table 51. Novartis Recombinant Vector Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 52. GSK Corporate Summary
Table 53. GSK Recombinant Vector Vaccines Product Offerings
Table 54. GSK Recombinant Vector Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 55. CNBG Corporate Summary
Table 56. CNBG Recombinant Vector Vaccines Product Offerings
Table 57. CNBG Recombinant Vector Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 58. ChengDa Bio Corporate Summary
Table 59. ChengDa Bio Recombinant Vector Vaccines Product Offerings
Table 60. ChengDa Bio Recombinant Vector Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 61. Changsheng Life Corporate Summary
Table 62. Changsheng Life Recombinant Vector Vaccines Product Offerings
Table 63. Changsheng Life Recombinant Vector Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 64. Zhifei Corporate Summary
Table 65. Zhifei Recombinant Vector Vaccines Product Offerings
Table 66. Zhifei Recombinant Vector Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 67. SINOVAC BIOTECH Corporate Summary
Table 68. SINOVAC BIOTECH Recombinant Vector Vaccines Product Offerings
Table 69. SINOVAC BIOTECH Recombinant Vector Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 70. NuoCheng Bio Corporate Summary
Table 71. NuoCheng Bio Recombinant Vector Vaccines Product Offerings
Table 72. NuoCheng Bio Recombinant Vector Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 73. Hualan Bio Corporate Summary
Table 74. Hualan Bio Recombinant Vector Vaccines Product Offerings
Table 75. Hualan Bio Recombinant Vector Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 76. Kangtai Corporate Summary
Table 77. Kangtai Recombinant Vector Vaccines Product Offerings
Table 78. Kangtai Recombinant Vector Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 79. Recombinant Vector Vaccines Production Capacity (K Doses) of Key Manufacturers in Global Market, 2020-2022 (K Doses)
Table 80. Global Recombinant Vector Vaccines Capacity Market Share of Key Manufacturers, 2020-2022
Table 81. Global Recombinant Vector Vaccines Production by Region, 2017-2022 (K Doses)
Table 82. Global Recombinant Vector Vaccines Production by Region, 2023-2028 (K Doses)
Table 83. Recombinant Vector Vaccines Market Opportunities & Trends in Global Market
Table 84. Recombinant Vector Vaccines Market Drivers in Global Market
Table 85. Recombinant Vector Vaccines Market Restraints in Global Market
Table 86. Recombinant Vector Vaccines Raw Materials
Table 87. Recombinant Vector Vaccines Raw Materials Suppliers in Global Market
Table 88. Typical Recombinant Vector Vaccines Downstream
Table 89. Recombinant Vector Vaccines Downstream Clients in Global Market
Table 90. Recombinant Vector Vaccines Distributors and Sales Agents in Global Market
Table 1. Key Players of Recombinant Vector Vaccines in Global Market
Table 2. Top Recombinant Vector Vaccines Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Recombinant Vector Vaccines Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Recombinant Vector Vaccines Revenue Share by Companies, 2017-2022
Table 5. Global Recombinant Vector Vaccines Sales by Companies, (K Doses), 2017-2022
Table 6. Global Recombinant Vector Vaccines Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Recombinant Vector Vaccines Price (2017-2022) & (USD/Dose)
Table 8. Global Manufacturers Recombinant Vector Vaccines Product Type
Table 9. List of Global Tier 1 Recombinant Vector Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Recombinant Vector Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Recombinant Vector Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Recombinant Vector Vaccines Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Recombinant Vector Vaccines Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Recombinant Vector Vaccines Sales (K Doses), 2017-2022
Table 15. By Type - Global Recombinant Vector Vaccines Sales (K Doses), 2023-2028
Table 16. By Application – Global Recombinant Vector Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Recombinant Vector Vaccines Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Recombinant Vector Vaccines Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Recombinant Vector Vaccines Sales (K Doses), 2017-2022
Table 20. By Application - Global Recombinant Vector Vaccines Sales (K Doses), 2023-2028
Table 21. By Region – Global Recombinant Vector Vaccines Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Recombinant Vector Vaccines Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Recombinant Vector Vaccines Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Recombinant Vector Vaccines Sales (K Doses), 2017-2022
Table 25. By Region - Global Recombinant Vector Vaccines Sales (K Doses), 2023-2028
Table 26. By Country - North America Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Recombinant Vector Vaccines Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Recombinant Vector Vaccines Sales, (K Doses), 2017-2022
Table 29. By Country - North America Recombinant Vector Vaccines Sales, (K Doses), 2023-2028
Table 30. By Country - Europe Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Recombinant Vector Vaccines Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Recombinant Vector Vaccines Sales, (K Doses), 2017-2022
Table 33. By Country - Europe Recombinant Vector Vaccines Sales, (K Doses), 2023-2028
Table 34. By Region - Asia Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Recombinant Vector Vaccines Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Recombinant Vector Vaccines Sales, (K Doses), 2017-2022
Table 37. By Region - Asia Recombinant Vector Vaccines Sales, (K Doses), 2023-2028
Table 38. By Country - South America Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Recombinant Vector Vaccines Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Recombinant Vector Vaccines Sales, (K Doses), 2017-2022
Table 41. By Country - South America Recombinant Vector Vaccines Sales, (K Doses), 2023-2028
Table 42. By Country - Middle East & Africa Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Recombinant Vector Vaccines Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Recombinant Vector Vaccines Sales, (K Doses), 2017-2022
Table 45. By Country - Middle East & Africa Recombinant Vector Vaccines Sales, (K Doses), 2023-2028
Table 46. SANOFI PASTEUR S.A. Corporate Summary
Table 47. SANOFI PASTEUR S.A. Recombinant Vector Vaccines Product Offerings
Table 48. SANOFI PASTEUR S.A. Recombinant Vector Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 49. Novartis Corporate Summary
Table 50. Novartis Recombinant Vector Vaccines Product Offerings
Table 51. Novartis Recombinant Vector Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 52. GSK Corporate Summary
Table 53. GSK Recombinant Vector Vaccines Product Offerings
Table 54. GSK Recombinant Vector Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 55. CNBG Corporate Summary
Table 56. CNBG Recombinant Vector Vaccines Product Offerings
Table 57. CNBG Recombinant Vector Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 58. ChengDa Bio Corporate Summary
Table 59. ChengDa Bio Recombinant Vector Vaccines Product Offerings
Table 60. ChengDa Bio Recombinant Vector Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 61. Changsheng Life Corporate Summary
Table 62. Changsheng Life Recombinant Vector Vaccines Product Offerings
Table 63. Changsheng Life Recombinant Vector Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 64. Zhifei Corporate Summary
Table 65. Zhifei Recombinant Vector Vaccines Product Offerings
Table 66. Zhifei Recombinant Vector Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 67. SINOVAC BIOTECH Corporate Summary
Table 68. SINOVAC BIOTECH Recombinant Vector Vaccines Product Offerings
Table 69. SINOVAC BIOTECH Recombinant Vector Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 70. NuoCheng Bio Corporate Summary
Table 71. NuoCheng Bio Recombinant Vector Vaccines Product Offerings
Table 72. NuoCheng Bio Recombinant Vector Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 73. Hualan Bio Corporate Summary
Table 74. Hualan Bio Recombinant Vector Vaccines Product Offerings
Table 75. Hualan Bio Recombinant Vector Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 76. Kangtai Corporate Summary
Table 77. Kangtai Recombinant Vector Vaccines Product Offerings
Table 78. Kangtai Recombinant Vector Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 79. Recombinant Vector Vaccines Production Capacity (K Doses) of Key Manufacturers in Global Market, 2020-2022 (K Doses)
Table 80. Global Recombinant Vector Vaccines Capacity Market Share of Key Manufacturers, 2020-2022
Table 81. Global Recombinant Vector Vaccines Production by Region, 2017-2022 (K Doses)
Table 82. Global Recombinant Vector Vaccines Production by Region, 2023-2028 (K Doses)
Table 83. Recombinant Vector Vaccines Market Opportunities & Trends in Global Market
Table 84. Recombinant Vector Vaccines Market Drivers in Global Market
Table 85. Recombinant Vector Vaccines Market Restraints in Global Market
Table 86. Recombinant Vector Vaccines Raw Materials
Table 87. Recombinant Vector Vaccines Raw Materials Suppliers in Global Market
Table 88. Typical Recombinant Vector Vaccines Downstream
Table 89. Recombinant Vector Vaccines Downstream Clients in Global Market
Table 90. Recombinant Vector Vaccines Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Recombinant Vector Vaccines Segment by Type
Figure 2. Recombinant Vector Vaccines Segment by Application
Figure 3. Global Recombinant Vector Vaccines Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Recombinant Vector Vaccines Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Recombinant Vector Vaccines Revenue, 2017-2028 (US$, Mn)
Figure 7. Recombinant Vector Vaccines Sales in Global Market: 2017-2028 (K Doses)
Figure 8. The Top 3 and 5 Players Market Share by Recombinant Vector Vaccines Revenue in 2021
Figure 9. By Type - Global Recombinant Vector Vaccines Sales Market Share, 2017-2028
Figure 10. By Type - Global Recombinant Vector Vaccines Revenue Market Share, 2017-2028
Figure 11. By Type - Global Recombinant Vector Vaccines Price (USD/Dose), 2017-2028
Figure 12. By Application - Global Recombinant Vector Vaccines Sales Market Share, 2017-2028
Figure 13. By Application - Global Recombinant Vector Vaccines Revenue Market Share, 2017-2028
Figure 14. By Application - Global Recombinant Vector Vaccines Price (USD/Dose), 2017-2028
Figure 15. By Region - Global Recombinant Vector Vaccines Sales Market Share, 2017-2028
Figure 16. By Region - Global Recombinant Vector Vaccines Revenue Market Share, 2017-2028
Figure 17. By Country - North America Recombinant Vector Vaccines Revenue Market Share, 2017-2028
Figure 18. By Country - North America Recombinant Vector Vaccines Sales Market Share, 2017-2028
Figure 19. US Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Recombinant Vector Vaccines Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Recombinant Vector Vaccines Sales Market Share, 2017-2028
Figure 24. Germany Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2028
Figure 25. France Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Recombinant Vector Vaccines Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Recombinant Vector Vaccines Sales Market Share, 2017-2028
Figure 33. China Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2028
Figure 37. India Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Recombinant Vector Vaccines Revenue Market Share, 2017-2028
Figure 39. By Country - South America Recombinant Vector Vaccines Sales Market Share, 2017-2028
Figure 40. Brazil Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Recombinant Vector Vaccines Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Recombinant Vector Vaccines Sales Market Share, 2017-2028
Figure 44. Turkey Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2028
Figure 48. Global Recombinant Vector Vaccines Production Capacity (K Doses), 2017-2028
Figure 49. The Percentage of Production Recombinant Vector Vaccines by Region, 2021 VS 2028
Figure 50. Recombinant Vector Vaccines Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Recombinant Vector Vaccines Segment by Type
Figure 2. Recombinant Vector Vaccines Segment by Application
Figure 3. Global Recombinant Vector Vaccines Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Recombinant Vector Vaccines Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Recombinant Vector Vaccines Revenue, 2017-2028 (US$, Mn)
Figure 7. Recombinant Vector Vaccines Sales in Global Market: 2017-2028 (K Doses)
Figure 8. The Top 3 and 5 Players Market Share by Recombinant Vector Vaccines Revenue in 2021
Figure 9. By Type - Global Recombinant Vector Vaccines Sales Market Share, 2017-2028
Figure 10. By Type - Global Recombinant Vector Vaccines Revenue Market Share, 2017-2028
Figure 11. By Type - Global Recombinant Vector Vaccines Price (USD/Dose), 2017-2028
Figure 12. By Application - Global Recombinant Vector Vaccines Sales Market Share, 2017-2028
Figure 13. By Application - Global Recombinant Vector Vaccines Revenue Market Share, 2017-2028
Figure 14. By Application - Global Recombinant Vector Vaccines Price (USD/Dose), 2017-2028
Figure 15. By Region - Global Recombinant Vector Vaccines Sales Market Share, 2017-2028
Figure 16. By Region - Global Recombinant Vector Vaccines Revenue Market Share, 2017-2028
Figure 17. By Country - North America Recombinant Vector Vaccines Revenue Market Share, 2017-2028
Figure 18. By Country - North America Recombinant Vector Vaccines Sales Market Share, 2017-2028
Figure 19. US Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Recombinant Vector Vaccines Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Recombinant Vector Vaccines Sales Market Share, 2017-2028
Figure 24. Germany Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2028
Figure 25. France Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Recombinant Vector Vaccines Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Recombinant Vector Vaccines Sales Market Share, 2017-2028
Figure 33. China Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2028
Figure 37. India Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Recombinant Vector Vaccines Revenue Market Share, 2017-2028
Figure 39. By Country - South America Recombinant Vector Vaccines Sales Market Share, 2017-2028
Figure 40. Brazil Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Recombinant Vector Vaccines Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Recombinant Vector Vaccines Sales Market Share, 2017-2028
Figure 44. Turkey Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Recombinant Vector Vaccines Revenue, (US$, Mn), 2017-2028
Figure 48. Global Recombinant Vector Vaccines Production Capacity (K Doses), 2017-2028
Figure 49. The Percentage of Production Recombinant Vector Vaccines by Region, 2021 VS 2028
Figure 50. Recombinant Vector Vaccines Industry Value Chain
Figure 51. Marketing Channels
